KIORA PHARMACEUTICALS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $5.6M | $20.1M | $7.9M |
| FY2022 | $7.3M | $18.7M | $6.0M |
| FY2023 | $7.6M | $13.7M | $2.5M |
| FY2024 | $10.7M | $36.5M | $3.8M |
| FY2025 | $8.1M | $24.3M | $8.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $5.6M | $20.1M | $7.9M |
| FY2022 | $7.3M | $18.7M | $6.0M |
| FY2023 | $7.6M | $13.7M | $2.5M |
| FY2024 | $10.7M | $36.5M | $3.8M |
| FY2025 | $8.1M | $24.3M | $8.7M |